Apriori Bio
About:
Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.
Website: https://aprioribio.com
Twitter/X: AprioriBio
Top Investors: Flagship Pioneering, Coalition for Epidemic Preparedness Innovations
Description:
Apriori Bio is a health security company, aimed at protecting humanity against viral threats. The company uses a unique technology platform that enables the creation of variant-resilient vaccines and provides real-time insights to prepare for future outbreaks. Apriori Bio focuses on designing new vaccines and antibody drugs to combat existing and potential viral variants. With its innovative approach, the company aims to ensure durable protection against rapidly evolving viruses
$51.1M
Boston, Massachusetts, United States
2020-01-01
info(AT)aprioribio.com
Alex Goldsmith, Daniel Acker, Lovisa Afzelius, Noubar Afeyan
11-50
2024-07-08
Private
© 2025 bioDAO.ai